MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
+1.66%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$225M
AUM Growth
+$225M
(-5.9%)
Cap. Flow
-$19.7M
Cap. Flow
% of AUM
-8.77%
Top 10 Holdings %
Top 10 Hldgs %
56.15%
Holding
96
New
23
Increased
22
Reduced
21
Closed
14
Top Buys
| 1 |
Alibaba
BABA
|
$13.1M |
| 2 |
B
Barrick Mining Corporation
B
|
$11.9M |
| 3 |
Devon Energy
DVN
|
$6.55M |
| 4 |
PARA
Paramount Global Class B
PARA
|
$5.96M |
| 5 |
Cleveland-Cliffs
CLF
|
$5.17M |
Top Sells
| 1 |
VanEck Junior Gold Miners ETF
GDXJ
|
$20.6M |
| 2 |
Newmont
NEM
|
$18.4M |
| 3 |
Zoom
ZM
|
$13.3M |
| 4 |
PayPal
PYPL
|
$7.04M |
| 5 |
Occidental Petroleum
OXY
|
$6.83M |
Sector Composition
| 1 | Healthcare | 44.46% |
| 2 | Materials | 19.19% |
| 3 | Communication Services | 11.52% |
| 4 | Consumer Discretionary | 8.07% |
| 5 | Energy | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novavax
NVAX
$1.21B
| $2.29M | 0.33% |
285,000
+222,500
| +356% | +$1.79M |
|
27
Sprott Physical Silver Trust
PSLV
$7.48B
| $2.22M | 0.32% |
230,000
| – | – |
|
28
Q32 Bio
QTTB
$20.9M
| $1.98M | 0.29% |
+574,816
| New | +$1.98M |
|
29
FMC
FMC
$4.88B
| $1.94M | 0.28% |
+40,000
| New | +$1.94M |
|
30
Nektar Therapeutics
NKTR
$568M
| $1.89M | 0.27% |
2,032,868
+35,648
| +2% | +$33.2K |
|
31
Vanda Pharmaceuticals
VNDA
$279M
| $1.88M | 0.27% |
392,262
+188,836
| +93% | +$905K |
|
32
Heron Therapeutics
HRTX
$207M
| $1.86M | 0.27% |
1,212,743
-465,674
| -28% | -$712K |
|
33
The Mosaic Company
MOS
$10.6B
| $1.6M | 0.23% |
65,000
-125,000
| -66% | -$3.07M |
|
34
Roivant Sciences
ROIV
$8.15B
| $1.6M | 0.23% |
135,000
+35,000
| +35% | +$414K |
|
35
Maravai LifeSciences
MRVI
$350M
| $1.59M | 0.23% |
291,364
+216,364
| +288% | +$1.18M |
|
36
Schrodinger
SDGR
$1.44B
| $1.54M | 0.22% |
+80,000
| New | +$1.54M |
|
37
Alcoa
AA
$8.33B
| $1.51M | 0.22% |
40,000
-75,000
| -65% | -$2.83M |
|
38
StoneCo
STNE
$4.41B
| $1.39M | 0.2% |
+175,000
| New | +$1.39M |
|
39
Editas Medicine
EDIT
$231M
| $1.36M | 0.2% |
+1,069,732
| New | +$1.36M |
|
|
MREO
40
Mereo BioPharma
MREO
$272M
| $1.34M | 0.19% |
381,468
-3,067
| -0.8% | -$10.7K |
|
41
Jazz Pharmaceuticals
JAZZ
$7.75B
| $1.23M | 0.18% |
10,000
-15,000
| -60% | -$1.85M |
|
42
Forum Energy Technologies
FET
$315M
| $1.16M | 0.17% |
75,118
+6,709
| +10% | +$104K |
|
43
Oric Pharmaceuticals
ORIC
$994M
| $1.09M | 0.16% |
135,561
-15,000
| -10% | -$121K |
|
44
Wolfspeed
WOLF
$194M
| $999K | 0.14% |
+150,000
| New | +$999K |
|
45
Constellium
CSTM
$2.02B
| $991K | 0.14% |
+96,495
| New | +$991K |
|
46
Green Plains
GPRE
$728M
| $970K | 0.14% |
+102,278
| New | +$970K |
|
47
Banco Bradesco
BBD
$32.9B
| $860K | 0.12% |
+450,000
| New | +$860K |
|
48
ProQR Therapeutics
PRQR
$237M
| $786K | 0.11% |
296,618
-31,274
| -10% | -$82.9K |
|
49
Noble Corp
NE
$4.58B
| $785K | 0.11% |
+25,000
| New | +$785K |
|
50
GrowGeneration
GRWG
$102M
| $783K | 0.11% |
+463,046
| New | +$783K |
|